Topic Anticoagulation

Viewing 1–9 of 9

«
of 1
»

{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Venous Thromboembolism Risk Assessment and Prophylaxis: Facilitators and Barriers to Compliance with Clinical Guidelines in Acute Care
Price: $12.95
Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
Planner
{{ evaluation.question.text }}

{{choice.text}}

{{evaluation.answerSet[0].text}}
Test Code: JBIBP0419

Published: April 2019

Expires: 3/5/2021

Sources: JBI Best Practice Interactive Clinical Courses , Joanna Briggs Institute Evidence Best Practice Modules
Details

Required Passing Score: 7/10 (70%)

Authors: Sarahlouise White; Sherryl Gaston; Gary Misan

Categories: Acute Care , Advanced Practice Nursing , Cardiovascular , Evidence Based Practice , Physical Assessment/Diagnostic , Preventing Hospital Acquired Conditions (HAC) , Surgery

Specialties: Advanced Practice Nursing, Evidence-based practice, Quality Improvement, Surgery

Topics: Anticoagulation , Deep Vein Thrombosis (DVT) , Guideline , Joanna Briggs Institute , Postoperative Care , Prevention , Pulmonary Embolism (PE) , Venous Thromboembolism (VTE)
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Direct Oral Anticoagulants in Patients Cancer
Price: $12.95
Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
Planner
{{ evaluation.question.text }}

{{choice.text}}

{{evaluation.answerSet[0].text}}
Test Code: OT0419

Published: April 2019

Expires: 3/5/2021

Sources: Oncology Times
Details

Required Passing Score: 7/10 (70%)

Authors: Lisa Lohr, PharmD, BCPS, BCOP

Categories: Advanced Practice Nursing , Cancer

Specialties: Advanced Practice Nursing, Oncology

Topics: Anticoagulation , Deep Vein Thrombosis (DVT) , Direct Oral Anticoagulant (DOAC) , Venous Thromboembolism (VTE)
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Treatment with Intravenous Alteplase for Acute Ischemic Stroke After Reversal of Dabigatran with Idarucizumab: A Case Study
Price: $12.95
Credits:
- ANCC 1.0 CH / 1.0 APH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
Planner
{{ evaluation.question.text }}

{{choice.text}}

{{evaluation.answerSet[0].text}}
Test Code: JNN0119

Published: Jan 2019

Expires: 12/4/2020

Sources: Journal of Neuroscience Nursing
Details

Required Passing Score: 13/18 (72%)

Authors: Sheila Jala,MHSS MCN; Elizabeth O'Brien, GradDipNeuroSci, MNNP

Categories: Acute Care , Advanced Practice Nursing , Drug Therapy , Neurological

Specialties: Acute Care, Advanced Practice Nursing, Critical Care, Neurology

Topics: Alteplase , Anticoagulation , Dabigatran , Idarucizumab , Stroke , Thrombolytic Therapy
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} A Review on the New and Old Anticoagulants
Price: $15.00
Credits:
- ANCC 1.5 CH / 1.5 APH
- DC - BON 1.5 CH
- FL - BON 1.5 CH
- GA - BON 1.5 CH
Planner
{{ evaluation.question.text }}

{{choice.text}}

{{evaluation.answerSet[0].text}}
Test Code: ON0119D

Published: Jan/Feb 2019

Expires: 12/4/2020

Sources: Orthopaedic Nursing
Details

Required Passing Score: 14/20 (70%)

Authors: Kayla Myers, PharmD, MPH; Abbie Lyden, PharmD, BCPS

Categories: Advanced Pharmacology Hours , Advanced Practice Nursing

Specialties: Advanced Practice Nursing, Orthopaedics

Topics: Advanced Pharmacology Hours , Anticoagulation , Drug Update
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Reversal Agents for Oral Anticoagulants
Price: $17.95
Credits:
- ANCC 1.5 CH / 1.5 CH
- DC - BON 1.5 CH
- FL - BON 1.5 CH
- GA - BON 1.5 CH
Planner
{{ evaluation.question.text }}

{{choice.text}}

{{evaluation.answerSet[0].text}}
Test Code: NP1117A

Published: Nov 2017

Expires: 12/4/2020

Sources: The Nurse Practitioner: The American Journal of Primary Health Care
Details

Required Passing Score: 13/18 (72%)

Authors: Carrie L. Griffiths, PharmD, BCCCP; Mark L. Vestal; Spencer J. Livengood; Samantha Hicks, MSN, ACNP, CCRN

Categories: Acute Care , Advanced Practice Nursing , Drug Therapy , Pharmacology

Specialties: Advanced Practice Nursing, Primary Care

Topics: Advanced Pharmacology Hours , Anticoagulation , Reversal Agent
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Venous Thromboembolism: Updated Management Guidelines
Price: $17.95
Credits:
- ANCC 1.5 CH
- DC - BON 1.5 CH
- FL - BON 1.5 CH
- GA - BON 1.5 CH
Planner
{{ evaluation.question.text }}

{{choice.text}}

{{evaluation.answerSet[0].text}}
Test Code: AJN0517B

Published: May 2017

Expires: 3/4/2022

Sources: AJN, American Journal of Nursing
Details

Required Passing Score: 16/20 (80%)

Authors: Sarah Hudson Roberts, DNP, MSN, RN; Sherry Motes Lawrence, DNP, MSN, RN

Collections: Never Events: DVT & PE associated with knee and hip replacements

Categories: Drug Therapy , Evidence Based Practice , Preventing Hospital Acquired Conditions (HAC)

Specialties: Evidence-based practice, Medical-Surgical

Topics: Anticoagulation , Care Coordination , Guideline , Non-vitamin K Oral Anticoagulant (NOAC) , Patient Education , Pulmonary Embolism (PE) , Venous Thromboembolism (VTE)
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} A Review on the Reversal of the Old and New Anticoagulants
Price: $27.95
Credits:
- ANCC 3.0 CH / 3.0 APH
- DC - BON 3.0 CH
- FL - BON 3.0 CH
- GA - BON 3.0 CH
Planner
{{ evaluation.question.text }}

{{choice.text}}

{{evaluation.answerSet[0].text}}
Test Code: AENJ1016

Published: Oct/Dec 2016

Expires: 12/4/2020

Sources: Advanced Emergency Nursing Journal
Details

Required Passing Score: 13/18 (72%)

Authors: Abby Mynatt Bailey, PharmD, BCPS; Matthew C. Blackburn, PharmD, BCPS; John M. Crowley, PharmD, BCPS; Kari S. Horn, PharmD; Amy E. Schultz, PharmD; Stephanie Baker Justice, PharmD, BCPS

Categories: Advanced Practice Nursing , Drug Therapy , Emergency care , Pharmacology

Specialties: Advanced Practice Nursing, Emergency

Topics: Advanced Pharmacology Hours , Anticoagulation , Reversal Agent
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Waiting for the Antidote: The Journey of Idarucizumab as a Potential Specific Reversal Agent for Dabigatran (Pradaxa)
Price: $21.95
Credits:
- ANCC 2.0 CH / 1.5 APH
- DC - BON 2.0 CH
- FL - BON 2.0 CH
Planner
{{ evaluation.question.text }}

{{choice.text}}

{{evaluation.answerSet[0].text}}
Test Code: CNS0915

Published: Sep/Oct 2015

Expires: 9/3/2021

Sources: Clinical Nurse Specialist: The Journal for Advanced Nursing Practice
Details

Required Passing Score: 13/18 (72%)

Authors: Patricia Anne O'Malley, PhD, RN, CNS

Categories: Advanced Practice Nursing , Emergency care , Hematology

Specialties: Advanced Practice Nursing, Emergency, Trauma

Topics: Advanced Pharmacology Hours , Anticoagulation
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Impact of a Focused Approach for Discharge Teaching Regarding the Use of Aspirin as Anticoagulant After Joint Replacement Surgery
Price: $25.00
Credits:
- ANCC 2.5 CH
- DC - BON 2.5 CH
- FL - BON 2.5 CH
Planner
{{ evaluation.question.text }}

{{choice.text}}

{{evaluation.answerSet[0].text}}
Test Code: ON0715D

Published: Jul/Aug 2015

Expires: 6/4/2021

Sources: Orthopaedic Nursing
Details

Required Passing Score: 12/15 (80%)

Authors: Deborah Wittig-Wells, PhD, MSN, RN, BC-NE; Melinda Higgins, PhD; Erica Davis, BSN, RN; Ifeya Johnson, AAN, RN; Latalya Louis, BSN, RN; Olga Mason, BSN, RN; Jacqueline Samms-McPherson; Sandra Sims, MSN, RN; Ani Jacob, BSN, RN

Categories: Orthopaedics

Specialties: Orthopaedics

Topics: Anticoagulation , Educational Strategies , Postoperative Care

Viewing 1–9 of 9

«
of 1
»

CEConnection

Topic Anticoagulation

Show

Sort

{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Venous Thromboembolism Risk Assessment and Prophylaxis: Facilitators and Barriers to Compliance with Clinical Guidelines in Acute Care

Credits:

{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Direct Oral Anticoagulants in Patients Cancer

Credits:

{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Treatment with Intravenous Alteplase for Acute Ischemic Stroke After Reversal of Dabigatran with Idarucizumab: A Case Study

Credits:

{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} A Review on the New and Old Anticoagulants

Credits:

{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Reversal Agents for Oral Anticoagulants

Credits:

{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Venous Thromboembolism: Updated Management Guidelines

Credits:

{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} A Review on the Reversal of the Old and New Anticoagulants

Credits:

{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Waiting for the Antidote: The Journey of Idarucizumab as a Potential Specific Reversal Agent for Dabigatran (Pradaxa)

Credits:

{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Impact of a Focused Approach for Discharge Teaching Regarding the Use of Aspirin as Anticoagulant After Joint Replacement Surgery

Credits: